| ORZINDO BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)
1796310 17 Aug 2016 | on 27 Nov 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, auto-immune diseases, solid organ transplant rejection, hepatitis; pharmaceutical preparations for human use relating to metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents. | | | ORZINDO BRISTOL-MYERS SQUIBB COMPANY
1498031 30 Sep 2010 | on 19 Oct 2016 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of metabolic disorders namely diabetes, obesity, hyperlipidemia, insulin resistance, and metabolic syndrome. | | | ORZINDO BRISTOL-MYERS SQUIBB COMPANY
(A DELAWARE CORPORATION)
1253883 13 Apr 2005 | on 04 May 2011 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; diagnostic pharmaceutical preparations used to increase heart rate and contrast imaging agents. | | 
